サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1762538

レディトゥユース医薬品包装市場：業界動向と世界の予測 - 容器タイプ別、クロージャタイプ別、製造材料別、主要地域別

Ready to Use Pharmaceutical Packaging Market : Industry Trends and Global Forecasts - Distribution by Type of Container, Type of Closure, Material of Fabrication and Key Geographical Regions

出版日
ページ情報
英文 323 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.09円
レディトゥユース医薬品包装市場：業界動向と世界の予測 - 容器タイプ別、クロージャタイプ別、製造材料別、主要地域別
出版日: 2025年07月04日
発行: Roots Analysis
ページ情報: 英文 323 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レディトゥユース医薬品包装市場：概要

世界のレディトゥユース医薬品包装の市場規模は、2035年までの予測期間中に9.2%のCAGRで拡大し、現在の95億米ドルから2035年までに251億米ドルに成長すると予測されています。

市場セグメンテーションでは、市場規模および機会分析を以下のパラメータで区分しています：

容器タイプ

  • 滅菌カートリッジ
  • 滅菌シリンジ
  • 滅菌バイアル

クロージャタイプ

  • キャップ
  • プランジャー
  • シール
  • ストッパー
  • 先端キャップ/ニードルシールド

製造材料

  • アルミニウム
  • ガラス
  • プラスチック
  • ゴム

主な地域

  • 北米
  • 欧州
  • アジア
  • ラテンアメリカ
  • 中東・北アフリカ
  • その他の地域

医薬品包装市場の成長と動向

長年にわたり、米国食品医薬品局（US FDA）によって承認される医薬品は年間平均50品目程度であることが確認されています。さらに、世界全体で年間10万トン以上の医薬品が消費されているという調査結果もあります。医薬品パイプラインの増大は、それに関連する一次および二次医薬品包装ソリューションの需要増に不注意につながっています。しかし、従来の一次包装は、生産スケジュールの遅れや厳しい規制など、いくつかの課題を抱えています。このため、業界関係者は滅菌済み／RTU（レディトゥユース）一次包装ソリューションに重点を移すようになっています。

Ready to Use Pharmaceutical Packaging Market-IMG1

医薬品一次包装のRTUは、従来の一次包装に代わる有望な選択肢として登場し、医薬品の充填・仕上げ作業の合理化に大きな付加価値を与えています。これらのパッケージング・コンポーネントは、全体的な充填仕上げ製造における複数の工程（主に容器の洗浄、滅菌、準備）を省き、それによって既存の規制基準に準拠した業務効率の改善に役立っています。さらに、RTU包装システムはパイロジェン（体内に入ると発熱を引き起こす物質）を除去するために前処理され、医薬品成分が薬局方規格に適合することを保証します。医療用ポリマーが提供する他のいくつかの利点により、RTU容器密閉システムは製薬業界で徐々に人気を集めています。

RTU医薬品包装市場：主要インサイト

当レポートでは、RTU医薬品包装市場の現状を調査し、潜在的な成長機会を特定しています。主な調査結果は以下の通りです。

  • 現在、50社近くのメーカーが95種類以上の滅菌済み／レディトゥユース容器を販売または開発中であり、このうち2000年以前に設立されたメーカーの割合が比較的高いです。
  • レディトゥユース容器の45％近くがバイアルとして提供されており、これらの製品の大半はエチレンオキシド（EtO）を使用して滅菌されています。
  • 約85の滅菌済み／RTUクロージャーが世界中の企業別製造されており、そのうちの～60％はアジアに本社を置いています。
  • 幅広い種類のRTUクロージャーは、バイアル、シリンジ、カートリッジを含む様々なタイプの容器と互換性があり、生物製剤や低分子に最適な包装ソリューションを提供しています。
Ready to Use Pharmaceutical Packaging Market-IMG2
  • 競争力を得るため、RTU容器とクロージャーの製造に携わる企業は現在、それぞれの製品に高度な機能を組み込むことに注力しています。
  • 約40社が、さまざまな製薬業務の生産性と柔軟性を高めるために、自由度の異なるロボット機械を提供していると主張しています。
  • RTU容器とクロージャーの分野における利害関係者の関心の高まりは、パートナーシップの活動からも明らかです。
  • 当社の知的資本に基づき、利害関係者が滅菌済み／RTU一次包装業界への参入の実行可能性を評価できるようにする独自の枠組みを提案しました。
  • バイアル瓶は、今後、滅菌済み／RTU容器の需要の55％近くを占めると予想されます。
  • RTU一次包装市場は今後数年間CAGR 9.2%で成長すると予測され、主に滅菌済み/RTU容器から生み出される収益が原動力となっています。
Ready to Use Pharmaceutical Packaging Market-IMG3
  • RTU医薬品包装の予測機会は、異なるタイプの一次包装システム、製造材料、主要な地理的地域に分散している可能性が高いです。
  • 複雑な医薬品の要件に対応できる先進パッケージング材料と技術に対する需要の増加により、この業界にはいくつかの成長機会が存在します。

使用済み医薬品包装市場：主要セグメント

容器タイプ別では、市場は無菌カートリッジ、無菌シリンジ、無菌バイアルに区分されます。現在、無菌シリンジセグメントが世界のレディトゥユース医薬品包装市場で最大のシェアを占めています。さらに、無菌バイアルセグメンテーションのレディトゥユース医薬品包装市場は、予測期間中に最も高い市場成長の可能性を示すと予想されます。

クロージャータイプ別では、市場はキャップ、プランジャー、シール、ストッパー、チップキャップ/ニードルシールドに区分されます。現在、プランジャー部門が世界の既製医薬品包装市場で最大のシェアを占めています。しかし、キャップセグメントは予測期間中により高いCAGRで成長すると予想されます。

製造材料別では、市場はアルミニウム、ガラス、プラスチック、ゴムに区分されます。現在、プラスチックセグメントが世界のレディトゥユース医薬品包装市場で最も高い割合を占めています。次いで、予測期間中により高いCAGRでの成長が期待されるガラスセグメントです。

主要地域別に見ると、市場は北米、欧州、アジア、ラテンアメリカ、中東・アフリカ、その他に区分されます。現在、アジアは世界の既製医薬品包装市場を独占しており、最大の収益シェアを占めています。さらに、アジアの市場は今後より高いCAGRで成長する可能性が高いです。

医薬品包装市場の参入企業例

  • APG Pharma
  • Aptar
  • Daikyo Seiko
  • Datwyler
  • DWK Life Sciences
  • Ningbo Zhengli Pharmaceutical Packaging
  • SCHOTT
  • Stevanto
  • West Pharmaceutical Services

目次

第1章 序文

第2章 調査手法

第3章 経済的およびその他のプロジェクト特有の考慮事項

  • 章の概要
  • 市場力学

第4章 エグゼクティブサマリー

  • 章の概要

第5章 イントロダクション

  • 章の概要
  • 医薬品の包装と充填
  • レディトゥユース一次包装
  • 結論

第6章 滅菌済み/レディトゥユース容器：市場情勢

  • 章の概要
  • 滅菌済み/レディトゥユース容器：市場情勢
  • 滅菌済み/レディトゥユース容器：メーカー情勢

第7章 滅菌済み/レディトゥユースクロージャー：市場情勢

  • 章の概要
  • 滅菌済み/レディトゥユースクロージャー：市場情勢
  • 滅菌済み/レディトゥユースクロージャー：メーカーの情勢

第8章 重要な洞察

  • 章の概要
  • 滅菌済み/レディトゥユース容器：重要な洞察
  • 滅菌済み/レディトゥユースクロージャー：重要な洞察

第9章 製品競争力分析：滅菌済み/レディトゥユース容器

  • 章の概要
  • 滅菌済み/レディトゥユース容器：製品競争力分析

第10章 製品競争力分析：滅菌済み/レディトゥユースキャップ

  • 章の概要
  • 滅菌済み/レディトゥユースキャップ：製品競争力分析

第11章 企業プロファイル

  • 章の概要
  • APG Pharma Packaging
  • Aptar
  • Daikyo Seiko
  • Datwyler
  • DWK Life Sciences
  • Ningbo Zhengli Pharmaceutical Packaging
  • SCHOTT
  • Stevanato
  • West Pharmaceutical Services

第12章 パートナーシップとコラボレーション

  • 章の概要
  • パートナーシップモデル
  • 滅菌済み/レディトゥユース医薬品包装：パートナーシップとコラボレーション

第13章 市場参入意思決定の枠組み

  • 章の概要
  • 主要な前提と調査手法
  • 市場参入の意思決定に影響を与える主要なパラメータ
  • 結論

第14章 需要分析

  • 章の概要
  • 範囲と調査手法
  • 滅菌済み/レディトゥユース医薬品包装の世界需要：容器タイプ別
  • 滅菌済み/レディトゥユース医薬品包装の世界需要：クロージャタイプ別
  • 滅菌済み/レディトゥユース医薬品包装の世界需要：製造材料別
  • 滅菌済み/レディトゥユース医薬品包装の世界需要：主要地域別

第15章 市場影響分析：促進要因、抑制要因、機会、課題

第16章 世界の滅菌済み/レディトゥユース医薬品包装市場

  • 章の概要
  • 前提と調査手法
  • 世界の滅菌済み/レディトゥユース医薬品包装市場、歴史的動向（2018年以降）および予測（2035年まで）
  • 主要な市場セグメンテーション
  • ダイナミックダッシュボード

第17章 滅菌済み/レディトゥユース医薬品包装市場（容器タイプ別）

  • 章の概要
  • 主要な前提と調査手法
  • 滅菌済み/レディトゥユース医薬品包装市場：容器タイプ別
  • データの三角測量と検証

第18章 滅菌済み/レディトゥユース医薬品包装市場（クロージャタイプ別）

  • 章の概要
  • 主要な前提と調査手法
  • 滅菌済み/レディトゥユース医薬品包装市場：クロージャタイプ別
  • データの三角測量と検証

第19章 滅菌済み/レディトゥユース医薬品包装市場（製造材料別）

  • 章の概要
  • 主要な前提と調査手法
  • 滅菌済み/レディトゥユース医薬品包装市場：製造材料別
  • データの三角測量と検証

第20章 滅菌済み/レディトゥユース医薬品包装市場（主要地域別）

  • 章の概要
  • 主要な前提と調査手法
  • 北米
  • 欧州
  • アジア
  • ラテンアメリカ
  • 中東・北アフリカ
  • その他の地域
  • データの三角測量と検証

第21章 医薬品包装の新たな動向

  • 章の概要
  • 新たな動向
  • 結論

第22章 ケーススタディ：医薬品包装におけるロボット工学

  • 章の概要
  • 製薬業界におけるロボットの役割
  • 製薬業界向けロボットを提供する企業
  • 医薬品包装における機器統合型ロボットシステムを提供する企業
  • 結論

第23章 結論

第24章 エグゼクティブ洞察

第25章 付録1：表形式データ

第26章 付録2：企業・組織一覧

図表

List of Tables

  • Table 5.1 Compatibility of Polymers with Ethylene Oxide Sterilization
  • Table 5.2 Advantages and Disadvantages of Different Sterilization Techniques
  • Table 6.1 Pre-Sterilized / Ready to Use Containers: Information on Type of Container, Material(s) of Fabrication, Container Color and Type of Compatible Drug(s)
  • Table 6.2 Pre-Sterilized / Ready to Use Containers: Information on Scale of Operation, Packaging Format(s) and Sterilization Technique(s) Used
  • Table 6.3 Pre-Sterilized / Ready to Use Containers: Information on Quality Certification(s) Obtained and Target Market
  • Table 6.4 Pre-Sterilized / Ready to Use Containers: Information on Availability of Additional Coating and RTU Kits
  • Table 6.5 Pre-Sterilized / Ready to Use Containers: List of Manufacturers
  • Table 7.1 Pre-Sterilized / Ready to Use Closures: Information on Type of Closure, Material(s) of Fabrication, Type of Compatible Container(s), Type of Compatible Drug(s) and Sterilization Technique(s) Used
  • Table 7.2 Pre-Sterilized / Ready to Use Closures: Information on Available Finish Format(s), Quality Certification(s) Obtained and Target Market
  • Table 7.3 Pre-Sterilized / Ready to Use Closures: Information on Availability of Additional Coating
  • Table 7.4 Pre-Sterilized / Ready to Use Closures: List of Manufacturers
  • Table 11.1 Leading Ready to Use Container and Closure Manufacturers
  • Table 11.2 APG Pharma Packaging: Company Snapshot
  • Table 11.3 APG Pharma Packaging: Ready to Use Closures
  • Table 11.4 Aptar: Company Snapshot
  • Table 11.5 Aptar: Ready to Use Closures
  • Table 11.6 Aptar: Recent Developments and Future Outlook
  • Table 11.7 Daikyo Seiko: Company Snapshot
  • Table 11.8 Daikyo Seiko: Ready to Use Containers
  • Table 11.9 Daikyo Seiko: Ready to Use Closures
  • Table 11.10 Datwyler: Company Snapshot
  • Table 11.11 Datwyler: Ready to Use Closures
  • Table 11.12 Datwyler: Recent Developments and Future Outlook
  • Table 11.13 DWK Life Sciences: Company Snapshot
  • Table 11.14 DWK Life Sciences: Ready to Use Containers
  • Table 11.15 DWK Life Sciences: Ready to Use Closures
  • Table 11.16 DWK Life Sciences: Recent Developments and Future Outlook
  • Table 11.17 Ningbo Zhengli Pharmaceutical Packaging: Company Snapshot
  • Table 11.18 Ningbo Zhengli Pharmaceutical Packaging: Ready to Use Containers
  • Table 11.19 Ningbo Zhengli Pharmaceutical Packaging: Recent Developments and Future Outlook
  • Table 11.20 SCHOTT: Company Snapshot
  • Table 11.21 SCHOTT: Ready to Use Containers
  • Table 11.22 SCHOTT: Ready to Use Closures
  • Table 11.23 SCHOTT: Recent Developments and Future Outlook
  • Table 11.24 Stevanato: Company Snapshot
  • Table 11.25 Stevanato: Ready to Use Containers
  • Table 11.26 Stevanato: Ready to Use Closures
  • Table 11.27 Stevanato: Recent Developments and Future Outlook
  • Table 11.28 West Pharmaceutical Services: Company Snapshot
  • Table 11.29 West Pharmaceutical Services: Ready to Use Containers
  • Table 11.30 West Pharmaceutical Services: Ready to Use Closures
  • Table 11.31 West Pharmaceutical Services: Recent Developments and Future Outlook
  • Table 12.1 Pre-Sterilized / Ready to Use Containers and Closures: List of Partnerships and Collaborations, Since 2015
  • Table 14.1 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging: Distribution by Type of Container
  • Table 14.2 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging: Distribution by Type of Closure
  • Table 14.3 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging: Distribution by Material of Fabrication
  • Table 14.4 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging: Distribution by Key Geographical Regions
  • Table 16.1 Tiered Pricing Structure for Pre-Sterilized / RTU Pharmaceutical Packaging across Different Geographies
  • Table 22.1 List of Pharmaceutical Robotics Manufacturers
  • Table 22.2 Aseptic Technologies: Company Overview
  • Table 22.3 Aseptic Technologies: Key Specifications of Crystal L1 Robot Line
  • Table 22.4 Aseptic Technologies: Key Specifications of Crystal SL1 Robot Line
  • Table 22.5 AST: Company Overview
  • Table 22.6 AST: Key Specifications of ASEPTiCell
  • Table 22.7 AST: Key Specifications of GENiSYS R
  • Table 22.8 AST: Key Specifications of GENiSYS C
  • Table 22.9 AST: Key Specifications of GENiSYS Lab
  • Table 22.10 Bosch Packaging Technology: Company Overview
  • Table 22.11 Bosch Packaging Technology: Key Specifications of ATO
  • Table 22.12 Dara Pharma: Company Overview
  • Table 22.13 Dara Pharma: Key Specifications of SYX-E Cartridge + RABS
  • Table 22.14 Fedegari: Company Overview
  • Table 22.15 Fedegari: Key Specifications of Fedegari Isolator
  • Table 22.16 IMA: Company Overview
  • Table 22.17 IMA: Key Specifications of INJECTA
  • Table 22.18 IMA: Key Specifications of STERI LIF3
  • Table 22.19 Steriline: Company Overview
  • Table 22.20 Steriline: Key Specifications of Robotic Nest Filling Machine
  • Table 22.21 Steriline: Key Specifications of Robotic Vial Filling Machine
  • Table 22.22 Steriline: Key Specifications of Robotic Vial Capping Machine)
  • Table 22.23 Vanrx Pharmasystems: Company Overview
  • Table 22.24 Vanrx Pharmasystems: Key Specifications of Microcell Vial Filler
  • Table 22.25 Key Specifications of SA25 Aseptic Filling Workcell
  • Table 24.1 Jinan Youlyy Industrial: Company Snapshot
  • Table 24.2 Sagar Rubber: Company Snapshot
  • Table 24.3 Aseptic Technologies: Company Snapshot
  • Table 24.4 BioPhorum Operations: Company Snapshot
  • Table 24.5 PYRAMID Laboratories: Company Snapshot
  • Table 25.1 Pre-Sterilized / Ready to Use Containers: Distribution by Type of Container
  • Table 25.2 Pre-Sterilized / Ready to Use Containers: Distribution by Material(s) of Fabrication
  • Table 25.3 Pre-Sterilized / Ready to Use Containers: Distribution by Container Color
  • Table 25.4 Pre-Sterilized / Ready to Use Containers: Distribution by Type of Compatible Drug(s)
  • Table 25.5 Pre-Sterilized / Ready to Use Containers: Distribution by Scale of Operation
  • Table 25.6 Pre-Sterilized / Ready to Use Containers: Distribution by Packaging Format(s)
  • Table 25.7 Pre-Sterilized / Ready to Use Containers: Distribution by Sterilization Technique(s) Used
  • Table 25.8 Pre-Sterilized / Ready to Use Containers: Distribution by Quality Certification(s) Obtained
  • Table 25.9 Pre-Sterilized / Ready to Use Containers: Distribution by Target Market
  • Table 25.10 Pre-Sterilized / Ready to Use Containers: Distribution by Availability of Additional Coating
  • Table 25.11 Pre-Sterilized / Ready to Use Containers: Distribution by Availability of RTU Kits
  • Table 25.12 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Year of Establishment
  • Table 25.13 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Company Size
  • Table 25.14 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Location of Headquarters (Region-wise)
  • Table 25.15 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Location of Headquarters (Country-wise)
  • Table 25.16 Leading Manufacturers: Distribution by Number of Products
  • Table 25.17 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Closure
  • Table 25.18 Pre-Sterilized / Ready to Use Closures: Distribution by Material(s) of Fabrication
  • Table 25.19 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Compatible Container(s)
  • Table 25.20 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Compatible Drug(s)
  • Table 25.21 Pre-Sterilized / Ready to Use Closures: Distribution by Sterilization Technique(s) Used
  • Table 25.22 Pre-Sterilized / Ready to Use Closures: Distribution by Available Finish Format(s)
  • Table 25.23 Pre-Sterilized / Ready to Use Closures: Distribution by Quality Certification(s) Obtained
  • Table 25.24 Pre-Sterilized / Ready to Use Closures: Distribution by Target Market
  • Table 25.25 Pre-Sterilized / Ready to Use Closures: Distribution by Availability of Additional Coating
  • Table 25.26 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Year of Establishment
  • Table 25.27 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Company Size
  • Table 25.28 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Location of Headquarters (Region-wise)
  • Table 25.29 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Location of Headquarters (Country-wise)
  • Table 25.30 Leading Manufacturers: Distribution by Number of Products
  • Table 25.31 Key Insights: Distribution by Type of Container and Scale of Operation
  • Table 25.32 Key Insights: Distribution by Type of Container and Packaging Format(s)
  • Table 25.33 Key Insights: Distribution by Type of Container and Material(s) of Fabrication
  • Table 25.34 Key Insights: Distribution by Type of Container and Container Color
  • Table 25.35 Key Insights: Distribution by Type of Container and Sterilization Technique(s) Used
  • Table 25.36 Key Insights: Distribution by Type of Container and Type of Compatible Drug(s)
  • Table 25.37 Key Insights: Distribution by Material(s) of Fabrication and Sterilization Technique(s) Used
  • Table 25.38 Key Insights: Distribution by Type of Closure and Material(s) of Fabrication
  • Table 25.39 Key Insights: Distribution by Type of Closure and Sterilization Technique(s) Used
  • Table 25.40 Key Insights: Distribution by Type of Closure and Available Finish Format(s)
  • Table 25.41 Key Insights: Distribution by Type of Closure and Type of Compatible Drug(s)
  • Table 25.42 Aptar: Annual Revenues, Since 2016 (USD Billion)
  • Table 25.43 Datwyler: Annual Revenues, Since 2016 (CHF Billion)
  • Table 25.44 SCHOTT: Annual Revenues, Since 2019 (EUR Billion)
  • Table 25.45 West Pharmaceutical Services: Annual Revenues, Since 2018 (USD Billion)
  • Table 25.46 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2015
  • Table 25.47 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 25.48 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
  • Table 25.49 Partnerships and Collaborations: Distribution by Type of Partner
  • Table 25.50 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner, Since 2015
  • Table 25.51 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
  • Table 25.52 Partnerships and Collaborations: Distribution by Purpose(s) of Partnership
  • Table 25.53 Partnerships and Collaborations: Distribution by Type of Packaging System
  • Table 25.54 Partnerships and Collaborations: Distribution by Type of Packaging Material
  • Table 25.55 Most Active Players: Distribution by Number of Partnerships
  • Table 25.56 Partnerships and Collaborations: Local and International Agreements
  • Table 25.57 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Table 25.58 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, Till 2035: Distribution by Type of Container
  • Table 25.59 Demand for Pre-Sterilized / Ready to Use Vials, Till 2035
  • Table 25.60 Demand for Pre-Sterilized / Ready to Use Syringes, Till 2035
  • Table 25.61 Demand for Pre-Sterilized / Ready to Use Cartridges, Till 2035
  • Table 25.62 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, Till 2035: Distribution by Type of Closure
  • Table 25.63 Demand for Pre-Sterilized / Ready to Use Caps, Till 2035
  • Table 25.64 Demand for Pre-Sterilized / Ready to Use Plungers, Till 2035
  • Table 25.65 Demand for Pre-Sterilized / Ready to Use Seals, Till 2035
  • Table 25.66 Demand for Pre-Sterilized / Ready to Use Stoppers, Till 2035
  • Table 25.67 Demand for Pre-Sterilized / Ready to Use Tip Caps / Needle Shields, Till 2035
  • Table 25.68 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, Till 2035: Distribution by Material of Fabrication
  • Table 25.69 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Aluminum Containers and Closures, Till 2035
  • Table 25.70 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Glass Containers and Closures, Till 2035
  • Table 25.71 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Plastic Containers and Closures, Till 2035
  • Table 25.72 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Rubber Containers and Closures, Till 2035
  • Table 25.73 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, Till 2035: Distribution by Geography
  • Table 25.74 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in North America, Till 2035
  • Table 25.75 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Europe, Till 2035
  • Table 25.76 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Asia, Till 2035
  • Table 25.77 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Latin America, Till 2035
  • Table 25.78 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Middle East and North Africa, Till 2035
  • Table 25.79 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Rest of the World, Till 2035
  • Table 25.80 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.81 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, Till 2035: Optimistic Scenario
  • Table 25.82 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, Till 2035: Conservative Scenario
  • Table 25.83 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Vials: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.84 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Syringes: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.85 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Cartridges: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.86 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Caps: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.87 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Plungers: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.88 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Seals: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.89 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Stoppers: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.90 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Tip Caps / Needle Shields: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.91 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Aluminum Containers and Closures: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.92 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Glass Containers and Closures: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.93 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Plastic Containers and Closures: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.94 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Rubber Containers and Closures: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.95 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in North America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.96 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in North America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.97 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in North America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.98 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Europe: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.99 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Europe: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.100 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Europe: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.101 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Asia: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.102 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Asia: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.103 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Asia: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.104 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Latin America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.105 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Latin America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.106 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Latin America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.107 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Middle East and North Africa: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.108 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Middle East and North Africa: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.109 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Middle East and North Africa: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.110 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Rest of the World: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.111 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Rest of the World: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Table 25.112 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Rest of the World: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)

List of Figures

  • Figure 2.1 Research Methodology: Research Methodology
  • Figure 2.2 Research Methodology: Forecast Methodology
  • Figure 2.3 Research Methodology: Robust Quality Control
  • Figure 2.4 Research Methodology: Key Market Segmentation
  • Figure 4.1 Executive Summary: Pre-Sterilized / Ready to Use Containers Market Landscape
  • Figure 4.2 Executive Summary: Pre-Sterilized / Ready to Use Closures Market Landscape
  • Figure 4.3 Executive Summary: Partnerships and Collaborations
  • Figure 4.4 Executive Summary: Market Entry Decision Making Framework
  • Figure 4.5 Executive Summary: Demand Analysis
  • Figure 4.6 Executive Summary: Market Sizing and Opportunity Analysis
  • Figure 5.1 Advantages of Pharmaceutical Packaging
  • Figure 5.2 Type of Pharmaceutical Packaging
  • Figure 5.3 Innovation in Pharmaceutical Packaging and Value Chain
  • Figure 5.4 Ready to Use Enables Flexible, Flexible Aseptic Processing
  • Figure 5.5 Advantages of Ready to Use Platform
  • Figure 5.6 Drivers of Ready to Use Platform
  • Figure 6.1 Pre-Sterilized / Ready to Use Containers: Distribution by Type of Container
  • Figure 6.2 Pre-Sterilized / Ready to Use Containers: Distribution by Material(s) of Fabrication
  • Figure 6.3 Pre-Sterilized / Ready to Use Containers: Distribution by Container Color
  • Figure 6.4 Pre-Sterilized / Ready to Use Containers: Distribution by Type of Compatible Drug(s)
  • Figure 6.5 Pre-Sterilized / Ready to Use Containers: Distribution by Scale of Operation
  • Figure 6.6 Pre-Sterilized / Ready to Use Containers: Distribution by Packaging Format(s)
  • Figure 6.7 Pre-Sterilized / Ready to Use Containers: Distribution by Sterilization Technique(s) Used
  • Figure 6.8 Pre-Sterilized / Ready to Use Containers: Distribution by Quality Certification(s) Obtained
  • Figure 6.9 Pre-Sterilized / Ready to Use Containers: Distribution by Target Market
  • Figure 6.10 Pre-Sterilized / Ready to Use Containers: Distribution by Availability of Additional Coating
  • Figure 6.11 Pre-Sterilized / Ready to Use Containers: Distribution by Availability of RTU Kits
  • Figure 6.12 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Year of Establishment
  • Figure 6.13 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Company Size
  • Figure 6.14 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Location of Headquarters (Region-wise)
  • Figure 6.15 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Location of Headquarters (Country-wise)
  • Figure 6.16 Leading Manufacturers: Distribution by Number of Products
  • Figure 7.1 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Closure
  • Figure 7.2 Pre-Sterilized / Ready to Use Closures: Distribution by Material(s) of Fabrication
  • Figure 7.3 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Compatible Container(s)
  • Figure 7.4 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Compatible Drug(s)
  • Figure 7.5 Pre-Sterilized / Ready to Use Closures: Distribution by Sterilization Technique(s) Used
  • Figure 7.6 Pre-Sterilized / Ready to Use Closures: Distribution by Available Finish Format(s)
  • Figure 7.7 Pre-Sterilized / Ready to Use Closures: Distribution by Quality Certification(s) Obtained
  • Figure 7.8 Pre-Sterilized / Ready to Use Closures: Distribution by Target Market
  • Figure 7.9 Pre-Sterilized / Ready to Use Closures: Distribution by Availability of Additional Coating
  • Figure 7.10 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Year of Establishment
  • Figure 7.11 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Company Size
  • Figure 7.12 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Location of Headquarters (Region-wise)
  • Figure 7.13 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Location of Headquarters (Country-wise)
  • Figure 7.14 Leading Manufacturers: Distribution by Number of Products
  • Figure 8.1 Key Insights: Distribution by Type of Container and Scale of Operation
  • Figure 8.2 Key Insights: Distribution by Type of Container and Packaging Format(s)
  • Figure 8.3 Key Insights: Distribution by Type of Container and Material(s) of Fabrication
  • Figure 8.4 Key Insights: Distribution by Type of Container and Container Color
  • Figure 8.5 Key Insights: Distribution by Type of Container and Sterilization Technique(s) Used
  • Figure 8.6 Key Insights: Distribution by Type of Container and Type of Compatible Drug(s)
  • Figure 8.7 Key Insights: Distribution by Material(s) of Fabrication and Sterilization Technique(s) Used
  • Figure 8.8 Key Insights: Distribution by Type of Closure and Material(s) of Fabrication
  • Figure 8.9 Key Insights: Distribution by Type of Closure and Sterilization Technique(s) Used
  • Figure 8.10 Key Insights: Distribution by Type of Closure and Available Finish Format(s)
  • Figure 8.11 Key Insights: Distribution by Type of Closure and Type of Compatible Drug(s)
  • Figure 9.1 Product Competitiveness Analysis: Vials
  • Figure 9.2 Product Competitiveness Analysis: Syringes
  • Figure 9.3 Product Competitiveness Analysis: Bags
  • Figure 9.4 Product Competitiveness Analysis: Cartridges
  • Figure 10.1 Product Competitiveness Analysis: Stoppers
  • Figure 10.2 Product Competitiveness Analysis: Plungers
  • Figure 10.3 Product Competitiveness Analysis: Caps
  • Figure 10.4 Product Competitiveness Analysis: Tip Caps / Needle Shields
  • Figure 10.5 Product Competitiveness Analysis: Seals
  • Figure 11.1 Aptar: Annual Revenues, Since 2016 (USD Billion)
  • Figure 11.2 Datwyler: Annual Revenues, Since 2016 (CHF Billion)
  • Figure 11.3 SCHOTT: Annual Revenues, Since 2016 (EUR Billion)
  • Figure 11.4 West Pharmaceutical Services: Annual Revenues, Since 2018 (USD Billion)
  • Figure 12.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2015
  • Figure 12.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 12.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Figure 12.4 Partnerships and Collaborations: Distribution by Type of Partner
  • Figure 12.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner, Since 2015
  • Figure 12.6 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
  • Figure 12.7 Partnerships and Collaborations: Distribution by Purpose of Partnership
  • Figure 12.8 Partnerships and Collaborations: Distribution by Type of Packaging System
  • Figure 12.9 Partnerships and Collaborations: Distribution by Type of Packaging Material
  • Figure 12.10 Most Active Players: Distribution by Number of Partnerships
  • Figure 12.11 Partnerships and Collaborations: Local and International Agreements
  • Figure 12.12 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Figure 13.1 Spider Web Analysis: Product Reach
  • Figure 13.2 Spider Web Analysis: Product Differentiation
  • Figure 13.3 Spider Web Analysis: Market Activity
  • Figure 13.4 Spider Web Analysis: Product Competitiveness
  • Figure 13.5 Spider Web Analysis: Manufacturing Complexity
  • Figure 13.6 Market Entry Decision Making Framework: Concluding Remarks
  • Figure 14.1 Demand for Pre-Sterilized / Ready to Use Vials, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.2 Demand for Pre-Sterilized / Ready to Use Syringes, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.3 Demand for Pre-Sterilized / Ready to Use Cartridges, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.4 Demand for Pre-Sterilized / Ready to Use Caps, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.5 Demand for Pre-Sterilized / Ready to Use Plungers, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.6 Demand for Pre-Sterilized / Ready to Use Seals, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.7 Demand for Pre-Sterilized / Ready to Use Stoppers, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.8 Demand for Pre-Sterilized / Ready to Use Tip Caps / Needle Shields, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.9 Demand for Pre-Sterilized / Ready to Use Aluminum Containers and Closures, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.10 Demand for Pre-Sterilized / Ready to Use Glass Containers and Closures, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.11 Demand for Pre-Sterilized / Ready to Use Plastic Containers and Closures, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.12 Demand for Pre-Sterilized / Ready to Use Rubber Containers and Closures, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.13 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in North America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.14 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Europe, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.15 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Asia, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.16 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Latin America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.17 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Middle East and North Africa, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 14.18 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Rest of the World, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 16.1 Percentage Distribution of Production and Processing Costs for Primary Packaging Components
  • Figure 16.2 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 16.3 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market: Conservative Scenario
  • Figure 16.4 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market: Optimistic Scenario
  • Figure 16.5 Dynamic Dashboard
  • Figure 17.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market: Distribution by Type of Container (USD Billion)
  • Figure 17.2 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Vials: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 17.3 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Syringes: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 17.4 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Cartridges: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 18.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market: Distribution by Type of Closure (USD Billion)
  • Figure 18.2 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Caps: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 18.3 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Plungers: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 18.4 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Seals: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 18.5 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Stoppers: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 18.6 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Tip Caps / Needle Shields: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Billion)
  • Figure 19.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Aluminum Containers and Closures: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 19.2 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Glass Containers and Closures: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 19.3 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Plastic Containers and Closures: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 19.4 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Rubber Containers and Closures: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in North America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.2 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in North America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.3 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in North America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.4 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Europe: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.5 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Europe: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.6 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Europe: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.7 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Asia: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.8 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Asia: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.9 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Asia: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.10 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Latin America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.11 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Latin America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.12 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Latin America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.13 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Middle East and North Africa: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.14 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Middle East and North Africa: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.15 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Middle East and North Africa: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.6 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Rest of the World: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.17 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Rest of the World: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 20.18 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Rest of the World: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • Figure 21.1 Emerging Trends in Pharmaceutical Packaging
  • Figure 21.2 Future Growth Opportunities for Ready to Use Containers and Closures Based on Recent Trends
  • Figure 22.1 Key Considerations for Selecting a Robotic System
  • Figure 22.2 Pharmaceutical Manufacturing: Advantages of Robotic Systems
  • Figure 22.3 Pharmaceutical Manufacturing: Disadvantages of Robotic Systems
  • Figure 23.1 Concluding Remarks: Pre-Sterilized / Ready to Use Containers Market Landscape
  • Figure 23.2 Concluding Remarks: Pre-Sterilized / Ready to Use Closures Market Landscape
  • Figure 23.3 Concluding Remarks: Partnerships and Collaborations
  • Figure 23.4 Concluding Remarks: Market Entry Decision Making Framework
  • Figure 23.5 Concluding Remarks: Demand Analysis
  • Figure 23.6 Concluding Remarks: Market Forecast
目次
Product Code: RA100449

READY TO USE PHARMACEUTICAL PACKAGING MARKET: OVERVIEW

As per Roots Analysis, the global ready-to-use pharmaceutical packaging market is estimated to grow from USD 9.5 billion in the current year to USD 25.1 billion by 2035, at a CAGR of 9.2% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Container

  • Sterile Cartridges
  • Sterile Syringes
  • Sterile Vials

Type of Closure

  • Caps
  • Plungers
  • Seals
  • Stoppers
  • Tip Caps / Needle Shields

Material of Fabrication

  • Aluminum
  • Glass
  • Plastic
  • Rubber

Key Geographical Regions

  • North America
  • Europe
  • Asia
  • Latin America
  • Middle East and North Africa
  • Rest of the World

READY TO USE PHARMACEUTICAL PACKAGING MARKET: GROWTH AND TRENDS

Over the years, it has been identified that on an average, around 50 drugs are approved by the US Food and Drug Administration (US FDA) annually. Further, studies indicate that more than 100,000 tons of pharmaceutical products are consumed globally per year. The growing pipeline of pharmaceutical drug products has inadvertently led to an increase in the demand for their associated primary and secondary pharmaceutical packaging solutions. However, traditional primary packing is fraught with several challenges, including delayed production timelines and stringent regulations. This has prompted the industry stakeholders to shift their focus towards pre-sterilized / ready to use (RTU) primary packaging solutions.

Ready to Use Pharmaceutical Packaging Market - IMG1

The ready to use of pharmaceutical primary packaging has emerged as a promising alternative to conventional primary packaging, adding significant value to streamline pharmaceutical fill / finish operations. These packaging components eliminate multiple steps in the overall fill finished manufacturing (mainly washing, sterilizing and preparing containers), thereby, helping improve operational efficiencies in compliance with existing regulatory standards. Further, RTU packaging systems are pre-treated in order to remove pyrogens (substances that can induce fever when introduced into the body) to ensure that the drug components meet pharmacopeial standards. Owing to several other benefits offered by medical polymers, RTU container-closure systems have gradually gained popularity in the pharmaceutical industry.

READY TO USE PHARMACEUTICAL PACKAGING MARKET: KEY INSIGHTS

The report delves into the current state of the ready-to-use pharmaceutical packaging market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • Presently, over 95 pre-sterilized / ready-to-use containers are available or being developed by close to 50 manufacturers; a relatively larger proportion of these players were established before 2000.
  • Nearly 45% of the ready-to-use containers are being offered as vials; majority of these products are sterilized using ethylene oxide (EtO).
  • Around 85 pre-sterilized / RTU closures are being manufactured by players across the globe; ~60% of these firms are headquartered in Asia.
  • A wide range of RTU closures are compatible with different types of containers, including vials, syringes and cartridges, providing optimal packaging solutions for biologics and small molecules.
Ready to Use Pharmaceutical Packaging Market - IMG2
  • In pursuit of gaining a competitive edge, companies engaged in the manufacturing of RTU containers and closures are presently focusing on the integration of advanced features into their respective product offerings.
  • Around 40 companies claim to offer robotic machinery, with different degrees of freedom, to enhance the productivity and flexibility of various pharmaceutical operations.
  • The rising interest of stakeholders in the RTU containers and closures domain is also evident from the partnership activity; in fact, the maximum number of collaborations were inked in the last two years.
  • Based on our intellectual capital, we have proposed a proprietary framework enabling stakeholders to evaluate the viability of entering the pre-sterilized / RTU primary packaging industry.
  • Vials are expected to account for close to 55% of the demand for pre-sterilized / ready to use containers in the foreseen future.
  • The RTU primary packaging market is anticipated to grow at a CAGR of 9.2% over the next few years, primarily driven by the revenues generated from pre-sterilized / ready to use containers.
Ready to Use Pharmaceutical Packaging Market - IMG3
  • The projected opportunity of RTU pharmaceutical packaging is likely to be distributed across different types of primary packaging systems, materials of fabrication and key geographical regions.
  • Several growth opportunities exist in the industry owing to the increasing demand for advanced packaging materials and technologies that can accommodate the requirements of complex drug products.

READY TO USE PHARMACEUTICAL PACKAGING MARKET: KEY SEGMENTS

Sterile Syringes Segment holds the Largest Share of the Ready to Use Pharmaceutical Packaging Market

Based on the type of container, the market is segmented into sterile cartridges, sterile syringes and sterile vials. At present, the sterile syringes segment holds the maximum share of the global ready-to-use pharmaceutical packaging market. Further, the ready-to-use pharmaceutical packaging market for the sterile vials segment is expected to show the highest market growth potential during the forecast period.

By Type of Closure, Caps Segment is Expected to Grow at a Faster Pace During the Forecast Period

Based on the type of closure, the market is segmented into caps, plungers, seals, stoppers and tip caps / needle shields. At present, the plungers segment holds the maximum share of the global ready-to-use pharmaceutical packaging market. However, the market for caps segment is expected to grow at a higher CAGR during the forecast period.

By Material of Fabrication, Plastic Segment Accounts for the Largest Share of the Global Ready to Use Pharmaceutical Packaging Market

Based on the material of fabrication, the market is segmented into aluminum, glass, plastic and rubber. Currently, the plastic segment captures the highest proportion of the global ready-to-use pharmaceutical packaging market. This is followed by the glass segment which is expected to grow at a higher CAGR during the forecast period.

Asia Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia, Latin America, Middle East and North Africa, and Rest of the World. Currently, Asia dominates the global ready-to-use pharmaceutical packaging market and accounts for the largest revenue share. Further, the market in Asia is likely to grow at a higher CAGR in the coming future.

Example Players in the Ready to Use Pharmaceutical Packaging Market

  • APG Pharma
  • Aptar
  • Daikyo Seiko
  • Datwyler
  • DWK Life Sciences
  • Ningbo Zhengli Pharmaceutical Packaging
  • SCHOTT
  • Stevanto
  • West Pharmaceutical Services

READY TO USE PHARMACEUTICAL PACKAGING MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global ready-to-use pharmaceutical packaging market, focusing on key market segments, including [A] type of container, [B] type of closure, [C] material of fabrication and [D] key geographical regions.
  • Pre-Sterilized / Ready to Use Containers Market Landscape: A comprehensive evaluation of the pre-sterilized / ready to use containers, based on several relevant parameters, such as [A] type of container, [B] material(s) of fabrication, [C] container color, [D] type of compatible drug(s), [E] scale of operation, [F] packaging format(s), [G] sterilization technique(s) used, [H] quality certification(s) obtained, [I] target market, [J] availability of additional coating and RTU kits. Additionally, a comprehensive evaluation of pre-sterilized / ready to use container manufacturers, based on parameters, such as [A] year of establishment, [B] company size (in terms of number of employees) and [C] location of headquarters.
  • Pre-Sterilized / Ready to Use Closures Market Landscape: A comprehensive evaluation of the pre-sterilized / ready to use closures, based on several relevant parameters, such as [A] type of closure, [B] material(s) of fabrication, [C] type of compatible container(s), [D] type of compatible drug(s), [E] sterilization technique(s) used, [F] available finish format(s), [G] quality certification(s) obtained, [H] target market and [I] availability of additional coating. Additionally, a comprehensive evaluation of pre-sterilized / ready to use closure manufacturers, based on parameters, such as [A] year of establishment, [B] company size (in terms of number of employees) and [C] location of headquarters.
  • Key Insights: In-depth analysis of market trends in the pre-sterilized / ready to use containers and closures domain, based on relevant parameters, such as [A] type of container and scale of operation, [B] type of container and packaging format(s), [C] type of container and material(s) of fabrication, [D] type of container and container color, [E] type of container and sterilization technique(s) used, [F] type of container and type of compatible drug(s), [G] material(s) of fabrication and sterilization technique(s) used, [H] type of closure and material(s) of fabrication, [I] type of closure and sterilization technique(s) used, [J] type of closure and available finish format(s), and [K] type of closure and type of compatible drug(s).
  • Product Competitiveness Analysis for Pre-Sterilized / Ready to Use Containers: A comprehensive competitive analysis of various types of pre-sterilized / ready to use containers, examining factors, such as [A] company strength and [B] product competitiveness.
  • Product Competitiveness Analysis for Pre-Sterilized / Ready to Use Closures: A comprehensive competitive analysis of various types of pre-sterilized / ready to use closures, examining factors, such as [A] company strength and [B] product competitiveness.
  • Company Profiles: In-depth profiles of key players that are engaged in offering pre-sterilized / ready-to-use containers and closures, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
  • Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the ready-to-use pharmaceutical packaging market, based on several parameters, such as [A] year of partnership, [B] type of partnership. [C] type of partner, [D] focus area, [E] type of packaging system, [F] type of packaging material, [G] most active players and [H] geography.
  • Market Entry Decision Making Framework: A comprehensive framework to identify the unmet needs and assist players in entering the pre-sterilized / RTU primary packaging domain, focusing on various factors, such as [A] product reach, [B] market activity, [C] product differentiation, [D] competitiveness and [E] manufacturing complexity.
  • Demand Analysis: A detailed assessment of the current and future demand for pre-sterilized / ready to use containers and closures, based on various relevant parameters, such as [A] type of primary packaging system and [B] material of fabrication used.
  • Market Impact Analysis: A thorough analysis of various factors, such as drivers, restraints, opportunities, and existing challenges that are likely to impact market growth.
  • Case Study: A detailed discussion on the use of robotic machinery in pharmaceutical manufacturing and fill / finish operations, featuring the various advantages of employing automation / automated technologies in such processes.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Key Market Insights
  • 1.3. Project Objectives
  • 1.4. Scope of the Report
  • 1.5. Inclusions and Exclusions
  • 1.6. Key Questions Answered
  • 1.7. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation
    • 2.7.9. Key Market Segmentations

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Future Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

  • 4.1. Chapter Overview

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Pharmaceutical Packaging and Filling
    • 5.2.1. Need for Pharmaceutical Packaging
    • 5.2.2. Types of Pharmaceutical Packaging
    • 5.2.3. Limitations of Traditional Primary Packaging
    • 5.2.4. Innovation in Pharmaceutical Packaging
  • 5.3. Ready to Use Primary Packaging
    • 5.3.1. Sterilization Techniques used in Primary Packaging
    • 5.3.2. Advantages of Ready to Use Primary Packaging
    • 5.3.3. Cost Saving Opportunities in Ready to Use Primary Packaging
    • 5.3.4. Current Demand for Ready to Use Primary Packaging
  • 5.4. Concluding Remarks

6. PRE-STERILIZED / READY TO USE CONTAINERS: MARKET LANDSCAPE

  • 6.1. Chapter Overview
  • 6.2. Pre-Sterilized / Ready to Use Containers: Overall Market Landscape
    • 6.2.1. Analysis by Type of Container
    • 6.2.2. Analysis by Material(s) of Fabrication
    • 6.2.3. Analysis by Container Color
    • 6.2.4. Analysis by Type of Compatible Drug(s)
    • 6.2.5. Analysis by Scale of Operation
    • 6.2.6. Analysis by Packaging Format(s)
    • 6.2.7. Analysis by Sterilization Technique(s) Used
    • 6.2.8. Analysis by Quality Certification(s) Obtained
    • 6.2.9. Analysis by Target Market
    • 6.2.10. Analysis by Availability of Additional Coating
    • 6.2.11. Analysis by Availability of RTU Kits
  • 6.3. Pre-Sterilized / Ready to Use Containers: Manufacturer Landscape
    • 6.3.1. Analysis by Year of Establishment
    • 6.3.2. Analysis by Company Size
    • 6.3.3. Analysis by Location of Headquarters
    • 6.3.4. Leading Manufacturers: Analysis by Number of Products

7. PRE-STERILIZED / READY TO USE CLOSURES: MARKET LANDSCAPE

  • 7.1. Chapter Overview
  • 7.2. Pre-Sterilized / Ready to Use Closures: Overall Market Landscape
    • 7.2.1. Analysis by Type of Closure
    • 7.2.2. Analysis by Material(s) of Fabrication
    • 7.2.3. Analysis by Type of Compatible Container(s)
    • 7.2.4. Analysis by Type of Compatible Drug(s)
    • 7.2.5. Analysis by Sterilization Technique(s) Used
    • 7.2.6. Analysis by Available Finish Format(s)
    • 7.2.7. Analysis by Quality Certification(s) Obtained
    • 7.2.8. Analysis by Target Market
    • 7.2.9. Analysis by Availability of Additional Coating
  • 7.3. Pre-Sterilized / Ready to Use Closures: Manufacturer Landscape
    • 7.3.1. Analysis by Year of Establishment
    • 7.3.2. Analysis by Company Size
    • 7.3.3. Analysis by Location of Headquarters
    • 7.3.4. Leading Manufacturers: Analysis by Number of Products

8. KEY INSIGHTS

  • 8.1. Chapter Overview
  • 8.2. Pre-Sterilized / Ready to Use Containers: Key Insights
    • 8.2.1. Analysis by Type of Container and Scale of Operation
    • 8.2.2. Analysis by Type of Container and Packaging Format(s)
    • 8.2.3. Analysis by Type of Container and Material(s) of Fabrication
    • 8.2.4. Analysis by Type of Container and Container Color
    • 8.2.5. Analysis by Type of Container and Sterilization Technique(s) Used
    • 8.2.6. Analysis by Type of Container and Type of Compatible Drug(s)
    • 8.2.7. Analysis by Material(s) of Fabrication and Sterilization Technique(s) Used
  • 8.3. Pre-Sterilized / Ready to Use Closures: Key Insights
    • 8.3.1. Analysis by Type of Closure and Material(s) of Fabrication
    • 8.3.2. Analysis by Type of Closure and Sterilization Technique(s) Used
    • 8.3.3. Analysis by Type of Closure and Available Finish Format(s)
    • 8.3.4. Analysis by Type of Closure and Type of Compatible Drug(s)

9. PRODUCT COMPETITIVENESS ANALYSIS: PRE-STERILIZED / READY TO USE CONTAINERS

  • 9.1. Chapter Overview
  • 9.2. Pre-Sterilized / Ready to Use Containers: Product Competitiveness Analysis
    • 9.2.1. Assumptions and Key Parameters
    • 9.2.2. Methodology
    • 9.2.3. Product Competitiveness Analysis: Vials
    • 9.2.4. Product Competitiveness Analysis: Syringes
    • 9.2.5. Product Competitiveness Analysis: Bags
    • 9.2.6. Product Competitiveness Analysis: Cartridges

10. PRODUCT COMPETITIVENESS ANALYSIS: PRE-STERILIZED / READY TO USE CLOSURES

  • 10.1. Chapter Overview
  • 10.2. Pre-Sterilized / Ready to Use Closures: Product Competitiveness Analysis
    • 10.2.1. Assumptions and Key Parameters
    • 10.2.2. Methodology
    • 10.2.3. Product Competitiveness Analysis: Stoppers
    • 10.2.4. Product Competitiveness Analysis: Plungers
    • 10.2.5. Product Competitiveness Analysis: Caps
    • 10.2.6. Product Competitiveness Analysis: Tip Caps / Needle Shields
    • 10.2.7. Product Competitiveness Analysis: Seals

11. COMPANY PROFILES

  • 11.1. Chapter Overview
  • 11.2. APG Pharma Packaging
    • 11.2.1. Company Overview
    • 11.2.2. Product Portfolio
      • 11.2.2.1. Ready to Use Closures
    • 11.2.3. Recent Developments and Future Outlook
  • 11.3. Aptar
    • 11.3.1. Company Overview
    • 11.3.2. Financial Information
    • 11.3.3. Product Portfolio
      • 11.3.3.1. Ready to Use Closures
    • 11.3.4. Recent Developments and Future Outlook
  • 11.4. Daikyo Seiko
    • 11.4.1. Company Overview
    • 11.4.2. Product Portfolio
      • 11.4.2.1. Ready to Use Containers
      • 11.4.2.2. Ready to Use Closures
    • 11.4.3. Recent Developments and Future Outlook
  • 11.5. Datwyler
    • 11.5.1. Company Overview
    • 11.5.2. Financial Information
    • 11.5.3. Product Portfolio
      • 11.5.3.1. Ready to Use Closures
    • 11.5.4. Recent Developments and Future Outlook
  • 11.6. DWK Life Sciences
    • 11.6.1. Company Overview
    • 11.6.2. Product Portfolio
      • 11.6.2.1. Ready to Use Containers
      • 11.6.2.2. Ready to Use Closures
    • 11.6.3. Recent Developments and Future Outlook
  • 11.7. Ningbo Zhengli Pharmaceutical Packaging
    • 11.7.1. Company Overview
    • 11.7.2. Product Portfolio
      • 11.7.2.1. Ready to Use Containers
    • 11.7.3. Recent Developments and Future Outlook
  • 11.8. SCHOTT
    • 11.8.1. Company Overview
    • 11.8.2. Financial Information
    • 11.8.3. Product Portfolio
      • 11.8.3.1. Ready to Use Containers
      • 11.8.3.2. Ready to Use Closures
    • 11.8.4. Recent Developments and Future Outlook
  • 11.9. Stevanato
    • 11.9.1. Company Overview
    • 11.9.2. Product Portfolio
      • 11.9.2.1. Ready to Use Containers
      • 11.9.2.2. Ready to Use Closures
    • 11.9.3. Recent Developments and Future Outlook
  • 11.10. West Pharmaceutical Services
    • 11.10.1. Company Overview
    • 11.10.2. Financial Information
    • 11.10.3. Product Portfolio
      • 11.10.3.1. Ready to Use Containers
      • 11.10.3.2. Ready to Use Closures
    • 11.10.4. Recent Developments and Future Outlook

12. PARTNERSHIPS AND COLLABORATIONS

  • 12.1. Chapter Overview
  • 12.2. Partnership Models
  • 12.3. Pre-Sterilized / Ready to Use Pharmaceutical Packaging: Partnerships and Collaborations
    • 12.3.1. Analysis by Year of Partnership
    • 12.3.2. Analysis by Type of Partnership
    • 12.3.3. Analysis by Year and Type of Partnership
    • 12.3.4. Analysis by Type of Partner
    • 12.3.5. Analysis by Year of Partnership and Type of Partner
    • 12.3.6. Analysis by Type of Partnership and Type of Partner
    • 12.3.7. Analysis by Purpose of Partnership
    • 12.3.8. Analysis by Type of Packaging System
    • 12.3.9. Analysis by Type of Packaging Material
    • 12.3.10. Most Active Players: Analysis by Number of Partnerships
    • 12.3.11. Analysis by Geography
      • 12.3.11.1. Intercontinental and Intracontinental Deals

13. MARKET ENTRY DECISION MAKING FRAMEWORK

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. Key Parameters Impacting Market Entry Decision Making
    • 13.3.1. Product Reach
    • 13.3.2. Product Differentiation
    • 13.3.3. Market Activity
    • 13.3.4. Product Competitiveness
    • 13.3.5. Manufacturing Complexity
  • 13.4. Concluding Remarks

14. DEMAND ANALYSIS

  • 14.1. Chapter Overview
  • 14.2. Scope and Methodology
  • 14.3. Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging: Distribution by Type of Container
    • 14.3.1. Pre-Sterilized / Ready to Use Vials, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.3.2. Pre-Sterilized / Ready to Use Syringes, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.3.3. Pre-Sterilized / Ready to Use Cartridges, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • 14.4. Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging: Distribution by Type of Closure
    • 14.4.1. Pre-Sterilized / Ready to Use Caps, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.4.2. Pre-Sterilized / Ready to Use Plungers, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.4.3. Pre-Sterilized / Ready to Use Seals, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.4.4. Pre-Sterilized / Ready to Use Stoppers, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.4.5. Pre-Sterilized / Ready to Use Tip Caps / Needle Shields, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • 14.5. Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging: Distribution by Material of Fabrication
    • 14.5.1. Pre-Sterilized / Ready to Use Aluminum Containers and Closures, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.5.2. Pre-Sterilized / Ready to Use Glass Containers and Closures, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.5.3. Pre-Sterilized / Ready to Use Plastic Containers and Closures, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.5.4. Pre-Sterilized / Ready to Use Rubber Containers and Closures, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • 14.6. Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging: Distribution by Key Geographical Region
    • 14.6.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in North America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.6.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Europe, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.6.3. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Asia, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.6.4. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Latin America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.6.5. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Middle East and North Africa, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 14.6.6. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Rest of the World, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)

15. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 15.1. Chapter Overview
  • 15.2. Market Drivers
  • 15.3. Market Restraints
  • 15.4. Market Opportunities
  • 15.5. Market Challenges
  • 15.6. Conclusion

16. GLOBAL PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET

  • 16.1. Chapter Overview
  • 16.2. Assumptions and Methodology
  • 16.3. Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 16.3.1. Scenario Analysis
      • 16.3.1.1. Conservative Scenario
      • 16.3.1.2. Optimistic Scenario
  • 16.4. Key Market Segmentations
  • 16.5. Dynamic Dashboard

17. PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET, BY TYPE OF CONTAINER

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Pre-Sterilized / Ready to use Pharmaceutical Packaging Market: Distribution by Type of Container
    • 17.3.1. Vials: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 17.3.2. Syringes: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 17.3.3. Cartridges: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • 17.4. Data Triangulation and Validation

18. PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET, BY TYPE OF CLOSURE

  • 18.1. Chapter Overview
  • 18.2. Key Assumptions and Methodology
  • 18.3. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market: Distribution by Type of Closure
    • 18.3.1. Caps: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 18.3.2. Plungers: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 18.3.3. Seals: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 18.3.4. Stoppers: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 18.3.5. Tip Caps / Needle Shields: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • 18.4. Data Triangulation and Validation

19. PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET, BY MATERIAL OF FABRICATION

  • 19.1. Chapter Overview
  • 19.2. Key Assumptions and Methodology
  • 19.3. Aluminum Containers and Closures: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • 19.4. Glass Containers and Closures: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • 19.5. Plastic Containers and Closures: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • 19.6. Rubber Containers and Closures: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
  • 19.7. Data Triangulation and Validation

20. PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET, BY KEY GEOGRAPHICAL REGION

  • 20.1. Chapter Overview
  • 20.2. Key Assumptions and Methodology
  • 20.3. North America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 20.3.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
    • 20.3.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures
  • 20.4. Europe: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 20.4.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
    • 20.4.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures
  • 20.5. Asia: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 20.5.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
    • 20.5.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures
  • 20.6. Latin America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 20.6.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
    • 20.6.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures
  • 20.7. Middle East and North Africa: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 20.7.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
    • 20.7.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures
  • 20.8. Rest of the World: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
    • 20.8.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
    • 20.8.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures
  • 20.9. Data Triangulation and Validation

21. EMERGING TRENDS IN PHARMACEUTICAL PACKAGING

  • 21.1. Chapter Overview
  • 21.2. Emerging Trends
    • 21.2.1. Preference for Self-Medication of Drugs, Through the Use of Modern Drug Delivery Devices
    • 21.2.2. Development of Improved Packaging Components and Efforts to Optimize Manufacturing Costs
    • 21.2.3. Availability of Modular Facilities
    • 21.2.4. Growing Demand and Preference for Personalized Therapies
    • 21.2.5. Rise in Provisions for Automating Fill / Finish Operations
    • 21.2.6. Surge in Partnership Activity
    • 21.2.7. Increase in Initiatives Undertaken by Industry Stakeholders in Developing Regions
  • 21.3. Concluding Remarks

22. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING

  • 22.1. Chapter Overview
  • 22.2. Role of Robotics in Pharmaceutical Industry
    • 22.2.1. Key Considerations for Selecting a Robotic System
    • 22.2.2. Advantages of Robotic Systems
    • 22.2.3. Disadvantages of Robotic Systems
  • 22.3. Companies Providing Robots for Use in Pharmaceutical Industry
  • 22.4. Companies Providing Equipment Integrated Robotic Systems in Pharmaceutical Packaging
    • 22.4.1. Aseptic Technologies
      • 22.4.1.1. Crystal L1 Robot Line
      • 22.4.1.2. Crystal SL1 Robot Line
    • 22.4.2. AST
      • 22.4.2.1. ASEPTiCELL
      • 22.4.2.2. GENiSYS R
      • 22.4.2.3. GENiSYS C
      • 22.4.2.4. GENiSYS Lab
    • 22.4.3. Bosch Packaging Technology
      • 22.4.3.1. ATO
    • 22.4.4. Dara Pharma
      • 22.4.4.1. SYX-E Cartridge + RABS
    • 22.4.5. Fedegari
      • 22.4.5.1. Fedegari Isolator
    • 22.4.6. IMA
      • 22.4.6.1. INJECTA
      • 22.4.6.2. STERI LIF3
    • 22.4.7. Steriline
      • 22.4.7.1. Robotic Nest Filling Machine (RNFM)
      • 22.4.7.2. Robotic Vial Filling Machine (RVFM)
      • 22.4.7.3. Robotic Vial Capping Machine (RVCM)
    • 22.4.8. Vanrx Pharmasystems
      • 22.4.8.1. Microcell Vial Filler
      • 22.4.8.2. SA25 Aseptic Filling Workcell
  • 22.5. Concluding Remarks

23. CONCLUSION

  • 23.1. Chapter Overview

24. EXECUTIVE INSIGHTS

  • 24.1. Chapter Overview
  • 24.2. Company A
    • 24.2.1. Company Snapshot
    • 24.2.2. Interview Transcript: Business Development Specialist
  • 24.3. Company B
    • 24.3.1. Company Snapshot
    • 24.3.2. Interview Transcript: Founder and Managing Director
  • 24.4. Company C
    • 24.4.1. Company Snapshot
    • 24.4.2. Interview Transcript: Business Development and Technology Director
  • 24.5. Company D
    • 24.5.1. Company Snapshot
    • 24.5.2. Interview Transcript: Former Facilitator
  • 24.6. Company E
    • 24.6.1. Company Snapshot
    • 24.6.2. Interview Transcript: Former Project Manager of Business Development

25. APPENDIX 1: TABULATED DATA

26. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATION